TELO insider transaction filings
Telomir Pharmaceuticals, Inc. — 9 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-27. Screen TELO transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-27 | 4 | Del Giudice Matthew Paul — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-07-27 | 4 | MacPherson Edward Clouston — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-07-27 | 4 | Whalen Matthew Pratt — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | Aminov Erez — CEO and Chairman, Director | Grant/award (A): 1,960,170 (derivative) · Disposition to issuer (D): 1,960,170 (derivative) · Grant/award (A): 2,000,000 (derivative) · Disposition to issuer (D): 2,000,000 (derivative) | EDGAR |
| 2026-05-22 | 4 | Whalen Matthew Pratt — Director | Grant/award (A): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) | EDGAR |
| 2026-05-22 | 4 | MacPherson Edward Clouston — Director | Grant/award (A): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) | EDGAR |
| 2026-05-22 | 4 | Del Giudice Matthew Paul — Director | Grant/award (A): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) | EDGAR |
| 2026-04-24 | 4 | Aminov Erez — CEO and Chairman, Director | Other (J): 7,319,710 @ $1.37 | EDGAR |
| 2025-05-30 | 4 | Aminov Erez — CEO and Chairman, Director | Grant/award (A): 2,000,000 (derivative) @ $0 · Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Telomir Pharmaceuticals, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-10 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-15 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-08 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-20 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-04-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-31 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-03-31 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-03-27 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-17 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=TELO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →